Philipp Sander
Investment Analyst, IndieBio

Philipp is an Investment Analyst with the IndieBio San Francisco office focusing on finding the best therapeutics and human health companies and nurturing a thriving IndieBio therapeutics ecosystem with portfolio companies, old and new. Philipp started his career with SOSV as a venture fellow scouting for exciting new companies, and continues to keep an eye on the cutting edge of science. At IndieBio, Philipp supports the portfolio with BD & partnering strategy, indication selection planning, technical troubleshooting and an odd experimental design or two.

Philipp received his PhD in Chemical Biology from the Scripps Research Institute in San Diego where dabbled in engineered biology, medicinal chemistry and biophysics while building a new drug discovery platform (ask him about his love for all things DNA). A dual native of picturesque Germany and sunny California, he has roamed the planet in search of cool science, exploring a breadth of topics including biomagnetism, RNA engineering, hematology and dinosaur eggs with stops in Bonn, Freiburg, Hong Kong and Berkeley.